Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Robert L. Ohsfeldt, PhD

Articles by Robert L. Ohsfeldt, PhD

Comparison of Low-density Lipoprotein Cholesterol Reduction After Switching Patients on Other Statins to Rosuvastatin or Simvastatin in a Real-world Clinical Practice Setting

ByKathleen M. Fox, PhD,Sanjay K. Gandhi, PhD,Robert L. Ohsfeldt, PhD,Michael H. Davidson, MD, FACC, FACP

December 1st 2007

Effectiveness and Cost-effectiveness of Rosuvastatin, Atorvastatin, and Simvastatin Among High-Risk Patients in Usual Clinical Practice

ByRobert L. Ohsfeldt, PhD,Sanjay K. Gandhi, PhD,Kathleen M. Fox, PhD, MPH,Thomas a. Stacy, PharmD,James M. McKenney, PharmD

November 1st 2006

Latest Updated Articles

Comparison of Low-density Lipoprotein Cholesterol Reduction After Switching Patients on Other Statins to Rosuvastatin or Simvastatin in a Real-world Clinical Practice Setting
Published: December 1st 2007 | Updated:
Effectiveness and Cost-effectiveness of Rosuvastatin, Atorvastatin, and Simvastatin Among High-Risk Patients in Usual Clinical Practice
Published: November 1st 2006 | Updated:

Trending on AJMC

Government Shutdown Could Disrupt Health Care Access

Most Medicare Beneficiaries Find Plan Shopping Confusing, Survey Finds

Rheumatoid Arthritis Linked to Elevated Pneumonia Risk, Especially in Seropositive Disease

FDA Approves Remibrutinib for Chronic Spontaneous Urticaria

Weighing Osimertinib vs Amivantamab-Lazertinib in Frontline EGFR NSCLC: Danny Nguyen, MD

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

© 2025 MJH Life Sciences^®

All rights reserved.